Cargando…
Recent Developments in Pharmacotherapy of Depression: Bench to Bedside
For the last 70 years, we did not move beyond the monoamine hypothesis of depression until the approval of the S-enantiomer of ketamine, an N-methyl-D-aspartate (NMDA) receptor blocker and the first non-monoaminergic antidepressant characterized by rapid antidepressant and antisuicidal effects. A si...
Autor principal: | Shad, Mujeeb U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223297/ https://www.ncbi.nlm.nih.gov/pubmed/37240943 http://dx.doi.org/10.3390/jpm13050773 |
Ejemplares similares
-
Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2021) -
Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
por: Li, Yutao, et al.
Publicado: (2022) -
Rett syndrome from bench to bedside: recent advances
por: Ehinger, Yann, et al.
Publicado: (2018) -
RECENT ADVANCES IN PSORIASIS: BENCH TO BEDSIDE
por: Raychaudhury, Siba P
Publicado: (2010) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)